Connect with us

Published

on

CEO of The Production Board David Friedberg walks to a morning session at the Allen & Company Sun Valley Conference on July 09, 2021 in Sun Valley, Idaho.
Kevin Dietsch | Getty Images

David Friedberg is known in Silicon Valley as an early Google executive who started farming insurance company Climate Corporation and sold it to Monsanto for $1 billion in 2013.

More recently, Friedberg has gained the nickname Queen of Quinoa on the popular All-In podcast with investors Jason Calacanis, Chamath Palihapitiya and David Sacks. The lifelong vegetarian earned the nickname when he purchased Canadian quinoa supplier NorQuin in 2014.

Friedberg remains board chairman at NorQuin and is chair of Metromile, a software-powered auto insurance provider that he started a decade ago and took public through a special purpose acquisition company earlier this year.

But he’s spending the bulk of his time on a project he started four years ago with the help of old friend and Google co-founder Larry Page.

After leaving Monsanto in 2015, Friedberg began talking with Page about a way to build and finance a whole new batch of start-ups focused on agriculture technology, sustainability and advancements in life sciences. He didn’t want to return to Google, so Page — through parent company Alphabet — agreed to help finance a holding company that Friedberg would operate.

Google CEO Larry Page holds a press annoucement at Google headquarters in New York on May 21, 2012. Google announced that it will allocate 22,000 square feet of its New York headquarters to CornellNYC Tech university, free of charge for five years and six month or until the university completes its campus in New York.
EMMANUEL DUNAND | AFP | Getty Images

Friedberg launched The Production Board in 2017. He’s now revealing Alphabet’s and Page’s involvement for the first time.

The company, which Friedberg describes as a venture foundry, just raised $300 million from Alphabet along with investors including Baillie Gifford, Allen & Co., BlackRock, Koch Disruptive Technologies and Morgan Stanley’s Counterpoint Global.

While Page was the initial Alphabet sponsor, Friedberg said the Google co-founder hasn’t been involved in the company for a while. Alphabet’s Anil Patel, who leads investments for the Other Bets segment, is on TPB’s board.

TPB is an investment company, but it’s not set up as a venture fund. That means Alphabet and other outside investors own shares in the parent entity but not the portfolio companies. They only get liquidity if TPB goes public or gets acquired.

“If one of our companies were to go public or get sold, we don’t take that capital and distribute it back to our shareholders,” Friedberg said in an interview this week. “It stays on the balance sheet and we keep building.”

No shortage of problems

Friedberg said neither he nor his investors need money, but they’re all trying to find solutions to some of the planet’s gravest existential challenges. With climate disasters emerging across the globe and more parts of the world becoming uninhabitable, TPB is investing in science and research to create new systems for food, agriculture and health.

“At least for my lifetime, I don’t think there’s going to be any shortage of problems and opportunities to go after,” the 41-year-old Friedberg said. “If we have a liquidity event, we should be able to recycle that capital and use it for new work.”

Friedberg said TPB has only 15 employees but its companies have hundreds of workers combined. His strategy is to hire top scientists, follow research trends for breakthroughs in genomics and life sciences and then fund R&D to determine if his team can develop a marketable product.

If there’s a business opportunity, TPB will spin the company out and give it a CEO, management team and lab space, while still offering centralized services for legal, human resources and finance. Some of the companies have raised additional capital from other venture investors.

“They can focus on getting a product built or getting product-market fit, and then over time as they mature, we start to hand some of those operating functions off so they can operate independently,” Friedberg said.

TPB’s existing investments include Soylent, the meal replacement beverage and nutrition company, and bioreactor lab Culture Biosciences.

Soylent
Josh Edelson | AFP | Getty Images

In a blog post Friday announcing the new investment, Friedberg is naming five foundry companies that TPB launched and turned into businesses. They include Pattern Ag, which is using precision engineering to help farmers make their land more productive; UR Labs, which makes a meal replacement shake to help people with diabetes lower their blood sugar; and Ohalo Genetics, a company using gene-editing tools to breed plants that use less land and water.

TPB also started Triplebar, a company using biotechnology to try to make food production, processing and packaging more sustainable. To run Triplebar, Friedberg teamed with Jeremy Agresti, a scientist and former Harvard fellow whose research was central to the creation of 10x Genomics.

Friedberg said seeking out and recruiting talent is a major part of his job.

“I love science,” he said. “Finding awesome scientists and trying to convince them to do this work is fun for me and a good use of my time.”

Along with hiring and raising capital, Friedberg has also been busy working on a SPAC. In February, he filed a prospectus for a blank-check company called TPB Acquisition, with plans to raise $250 million. He later reduced the target to $200 million.

The SPAC is looking for companies in the same markets that interest TPB. According to the filing, the transaction could even merge one of TPB’s businesses with another company.

“We will not, however, complete an initial business combination with only TPB or a portfolio company of TPB,” the filing said.

The SPAC hasn’t started trading or announced a deal, and Friedberg said he can’t talk about it at the moment.

WATCH: How the Western ‘megadrought’ could cause more ‘water wars’

Continue Reading

Technology

23andMe bankruptcy under congressional investigation for customer data

Published

on

By

23andMe bankruptcy under congressional investigation for customer data

Signage at 23andMe headquarters in Sunnyvale, California, U.S., on Wednesday, Jan. 27, 2021.

David Paul Morris | Bloomberg | Getty Images

The House Committee on Energy and Commerce is investigating 23andMe‘s decision to file for Chapter 11 bankruptcy protection and has expressed concern that its sensitive genetic data is “at risk of being compromised,” CNBC has learned.

Rep. Brett Guthrie, R-Ky., Rep. Gus Bilirakis, R-Fla., and Rep. Gary Palmer, R.-Ala., sent a letter to 23andMe’s interim CEO Joe Selsavage on Thursday requesting answers to a series of questions about its data and privacy practices by May 1.

The congressmen are the latest government officials to raise concerns about 23andMe’s commitment to data security, as the House Committee on Oversight and Government Reform and the Federal Trade Commission have sent the company similar letters in recent weeks.

23andMe exploded into the mainstream with its at-home DNA testing kits that gave customers insight into their family histories and genetic profiles. The company was once valued at a peak of $6 billion, but has since struggled to generate recurring revenue and establish a lucrative research and therapeutics businesses.

After filing for bankruptcy in in Missouri federal court in March, 23andMe’s assets, including its vast genetic database, are up for sale.

“With the lack of a federal comprehensive data privacy and security law, we write to express our great concern about the safety of Americans’ most sensitive personal information,” Guthrie, Bilirakis and Palmer wrote in the letter.

23andMe did not immediately respond to CNBC’s request for comment.

More CNBC health coverage

23andMe has been inundated with privacy concerns in recent years after hackers accessed the information of nearly 7 million customers in 2023. 

DNA data is particularly sensitive because each person’s sequence is unique, meaning it can never be fully anonymized, according to the National Human Genome Research Institute. If genetic data falls into the hands of bad actors, it could be used to facilitate identity theft, insurance fraud and other crimes.

The House Committee on Energy and Commerce has jurisdiction over issues involving data privacy. Guthrie serves as the chairman of the committee, Palmer serves as the chairman of the Subcommittee on Oversight and Investigations and Bilirakis serves as the chairman of the Subcommittee on Commerce, Manufacturing and Trade.

The congressmen said that while Americans’ health information is protected under legislation like the Health Insurance Portability and Accountability Act, or HIPAA, direct-to-consumer companies like 23andMe are typically not covered under that law. They said they feel “great concern” about the safety of the company’s customer data, especially given the uncertainty around the sale process.

23andMe has repeatedly said it will not change how it manages or protects consumer data throughout the transaction. Similarly, in a March release, the company said all potential buyers must agree to comply with its privacy policy and applicable law. 

“To constitute a qualified bid, potential buyers must, among other requirements, agree to comply with 23andMe’s consumer privacy policy and all applicable laws with respect to the treatment of customer data,” 23andMe said in the release.

23andMe customers can still delete their account and accompanying data through the company’s website. But Guthrie, Bilirakis and Palmer said there are reports that some users have had trouble doing so.

“Regardless of whether the company changes ownership, we want to ensure that customer access and deletion requests are being honored by 23andMe,” the congressmen wrote.

WATCH: The rise and fall of 23andMe

The rise and fall of 23andMe

Continue Reading

Technology

TSMC denies it’s talking to Intel about chipmaking joint venture

Published

on

By

TSMC denies it's talking to Intel about chipmaking joint venture

A motorcycle is seen near a building of the Taiwan Semiconductor Manufacturing Company (TSMC), which is a Taiwanese multinational semiconductor contract manufacturing and design company, in Hsinchu, Taiwan, on April 16, 2025.

Daniel Ceng | Anadolu | Getty Images

Taiwan Semiconductor Manufacturing Company denied reports that the semiconductor giant was in active discussions with Intel regarding a chipmaking joint venture.

“TSMC is not engaged in any discussion with other companies regarding any joint venture, technology licensing or technology,” CEO C.C. Wei said on the company’s first-quarter earnings call on Wednesday, dispelling rumors about a collaboration with Intel.

Intel and TSMC were said to have been looking to form a JV as recently as this month. On April 3, The Information reported that the two firms discussed a preliminary agreement to form a tie-up to operate Intel’s chip factories with TSMC owning a 21% stake.

Intel was not immediately available for comment when contacted by CNBC on Wei’s comments on Thursday. The company previously said it doesn’t comment on rumors, when asked by CNBC about the reported discussions.

Once the dominant chipmaker in the U.S., Intel has faced numerous challenges in recent years, losing ground to players like Nvidia, AMD, Qualcomm and Apple. Last year, Intel suffered its worst ever performance as a public company, with shares shedding 61% of their value.

TSMC’s denial of tie-up talks with Intel comes as President Donald Trump is pushing to address global trade imbalances and reshore manufacturing in the U.S. through tariffs. The Department of Commerce recently kicked off an investigation into semiconductor imports — a move that could result in new tariffs for the chip industry.

TSMC reported a profit beat for the first quarter thanks to a continued surge in demand for AI chips. However, the company contends with potential headwinds from Trump’s tariffs — which target Taiwan — and stricter export controls on TSMC clients Nvidia and AMD.

– CNBC’s Dylan Butts contributed to this report

Continue Reading

Technology

TSMC first-quarter profit tops estimates, rising 60%, but Trump trade policy threatens growth

Published

on

By

TSMC first-quarter profit tops estimates, rising 60%, but Trump trade policy threatens growth

A motorcycle is seen near a building of the Taiwan Semiconductor Manufacturing Company (TSMC), which is a Taiwanese multinational semiconductor contract manufacturing and design company, in Hsinchu, Taiwan, on April 16, 2025.

Daniel Ceng | Anadolu | Getty Images

Taiwan Semiconductor Manufacturing Company on Thursday beat profit expectations for the first quarter, thanks to a continued surge in demand for AI chips.

Here are TSMC’s first-quarter results versus LSEG consensus estimates:

  • Revenue: $839.25 billion New Taiwan dollars, vs. NT$835.13 billion expected
  • Net income: NT$361.56 billion, vs. NT$354.14 billion 

TSMC’s reported net income increased 60.3% from a year ago to NT$361.56 billion, while net revenue in the March quarter rose 41.6% from a year earlier to NT$839.25 billion.

The world’s largest contract chip manufacturer has benefited from the AI boom as it produces advanced processors for clients such American chip designer Nvidia.

However, the company faces headwinds from the trade policy of U.S. President Donald Trump, who has placed broad trade tariffs on Taiwan and stricter export controls on TSMC clients Nvidia and AMD.

Semiconductor export controls could also be expanded next month under the “AI diffusion rules” first proposed by the Biden administration, further restricting the sales of chipmakers that use TSMC foundries.

Taiwan currently faces a blanket 10% tariff from the Trump administration and that could rise to 32% after the President’s 90-day pause of his “reciprocal tariffs” ends unless it reaches a deal with the U.S.

As part of efforts to diversify its supply chains, TSMC has been investing billions in overseas facilities, though the lion’s share of its manufacturing remains in Taiwan.

In an apparent response to Trump’s trade policy, TSMC last month announced plans to invest an additional $100 billion in the U.S. on top of the $65 billion it has committed to three plants in the U.S.

On Monday, AMD said it would soon manufacture processor chips at one of the new Arizona-based TSMC facilities, marking the first time that its chips will be manufactured in the U.S.

The same day, Nvidia announced that it has already started production of its Blackwell chips at TSMC’s Arizona plants. It plans to produce up to half a trillion dollars of AI infrastructure in the U.S. over the next four years through partners, including TSMC.

Taiwan-listed shares of TSMC were down about 0.4%. Shares have lost about 20% so far this year.

Continue Reading

Trending